Publications by authors named "Steffen Thiel"

Introduction: Premature and low-birthweight infants are at especially high risk of perinatal complications, including impaired thermoregulation, infections and respiratory distress. Such adverse effects and the need for invasive procedures are associated with high mortality among preterms. This study focused on the influence of the innate immune system and tested the levels of collectins, collectin-10 (CL-10), collectin-11 (CL-11) and mannose-binding lectin (MBL) in preterm neonates.

View Article and Find Full Text PDF

Mannan-binding lectin (MBL) initiates the lectin pathway of complement and has been linked to albuminuria and mortality in diabetes. We hypothesize that MBL-associated serine protease 2 (MASP-2) deficiency will protect against diabetes-induced kidney damage. Male C57BL/6J MASP-2 knockout (Masp2) mice and wildtype (WT) mice were divided into a diabetic group and a non-diabetic group.

View Article and Find Full Text PDF

Autoreactivity of the complement system may escalate the development of diabetic nephropathy. We used the BTBR OB mouse model of type 2 diabetes to investigate the role of the complement factor mannan-binding lectin (MBL) in diabetic nephropathy. Female BTBR OB mice ( = 30) and BTBR non-diabetic WT mice ( = 30) were included.

View Article and Find Full Text PDF

When the membrane protein CD40 ligand (CD40L) on activated T cells binds the receptor CD40 on B-cells, it provides a co-stimulatory signal for B cell activation. Dysregulation of the CD40L:CD40 axis is associated with inflammatory and autoimmune diseases. The presence of soluble CD40L (sCD40L) in plasma is implicated in several diseases, from cardiovascular and autoimmune diseases to different types of cancer, and sCD40L has been suggested as a valuable marker of disease.

View Article and Find Full Text PDF
Article Synopsis
  • The study aimed to identify lectin pathway proteins (LPPs) as potential biomarkers for diagnosing axial spondyloarthritis (axSpA) in patients with either newly diagnosed axSpA or chronic low back pain (cLBP).
  • Serum samples from 515 participants were analyzed, revealing significant differences in levels of certain proteins between axSpA patients and those with cLBP, particularly showing higher L-ficolin, MASP-2, and C3dg in axSpA patients.
  • The combination of HLA-B27 with specific LPP measurements enhanced the diagnostic specificity for axSpA, but this came at the cost of sensitivity; C3dg and MASP-3 were highlighted as important markers
View Article and Find Full Text PDF

Background: Hereditary angioedema (HAE) is a genetic disorder that manifests as recurrent angioedema attacks, most frequently due to absent or reduced C1 inhibitor (C1INH) activity. C1INH is a crucial regulator of enzymatic cascades in the complement, fibrinolytic, and contact systems. Inter-α-trypsin inhibitor heavy chain 4 (ITIH4) is an abundant plasma protease inhibitor that can inhibit enzymes in the proteolytic pathways associated with HAE.

View Article and Find Full Text PDF

Background: This study aimed to evaluate the diagnostic and prognostic potential of MAp19, a regulating component of the lectin pathway of the complement system, in patients with suspected functionally relevant coronary artery disease (fCAD) as well as the determinants of MAp19 levels.

Methods: The presence of fCAD was adjudicated using myocardial perfusion imaging with single-photon emission tomography and, where available, coronary angiography. MAp19 levels were measured in participants at rest, at peak stress tests, and two hours after the stress.

View Article and Find Full Text PDF

Background: Sodium-glucose cotransporter 2 (SGLT- 2) inhibitors exert cardiovascular and kidney-protective effects in people with diabetes. Attenuation of inflammation could be important for systemic protection. The lectin pathway of complement system activation is linked to diabetic nephropathy.

View Article and Find Full Text PDF
Article Synopsis
  • - Various subspecies of the parasite Trypanosoma brucei are responsible for sleeping sickness, a disease that impacts millions of people and animals and thrives on immune evasion strategies.
  • - The study examines the structure and immune evasion role of the invariant surface glycoprotein gp75 (ISG75), showing its unique globular head and coiled-coil domains.
  • - ISG75 interacts with human IgG, which inhibits the immune response by blocking key pathways that usually target the parasite, showcasing a new way T. brucei escapes detection.
View Article and Find Full Text PDF

Background: We aimed to test the diagnostic and prognostic ability of H-ficolin, an initiator of the lectin pathway of the complement system, for functionally relevant coronary artery disease (fCAD), and explore its determinants.

Methods: The presence of fCAD was adjudicated using myocardial perfusion imaging single-photon emission tomography and coronary angiography. H-ficolin levels were measured by a sandwich-type immunoassay at rest, peak stress-test, and 2 h after stress-test.

View Article and Find Full Text PDF
Article Synopsis
  • Elevated levels of L-ficolin and M-ficolin proteins were found in patients with axial spondyloarthritis (axSpA) compared to healthy individuals and those with non-specific low back pain (LBP).
  • The study analyzed protein levels in two patient groups: one with various types of LBP and another undergoing adalimumab (ADA) therapy for axSpA.
  • Results showed that L-ficolin and M-ficolin were significantly reduced after ADA treatment, highlighting their role in the inflammatory processes associated with axSpA.
View Article and Find Full Text PDF

Kidney organoids are a promising model to study kidney disease, but their use is constrained by limited knowledge of their functional protein expression profile. Here, we define the organoid proteome and transcriptome trajectories over culture duration and upon exposure to TNFα, a cytokine stressor. Older organoids increase deposition of extracellular matrix but decrease expression of glomerular proteins.

View Article and Find Full Text PDF
Article Synopsis
  • Trypanosomes activate the complement system but avoid complete activation, particularly through the invariant surface glycoprotein ISG65 from Trypanosoma brucei, which interacts with complement proteins.
  • Research shows that ISG65 does not hinder the formation or function of C3 convertases but is a strong inhibitor of C3 deposition via the alternative pathway.
  • ISG65 enhances the conversion of C3b to iC3b, helping trypanosomes evade immune response, possibly by modifying C3b or facilitating interactions with other complement factors.
View Article and Find Full Text PDF

Complement activation is a hallmark of systemic lupus erythematosus (SLE) and can proceed through the classical (CP), lectin (LP), or alternative pathway (AP). When managing SLE patients, pathway-specific complement activation is rarely monitored as clinical assays are unavailable. In this study, we aim to differentiate between CP- or LP-mediated complement activation in SLE patients by quantifying pathway-specific protein complexes, namely C1s/C1-inhibitor (C1-INH) (CP-specific activation) and MASP-1/C1-INH (LP-specific activation).

View Article and Find Full Text PDF
Article Synopsis
  • The study focuses on how certain antibodies (Abs) can activate the complement system, which helps fight infections and cancer, but traditional Abs require complex interactions to do so effectively.
  • Researchers created bispecific single-domain Abs that can bind to both the C1 protein (part of the complement system) and cancer cell surface antigens at the same time, enhancing the activation of the complement.
  • Their results indicate these new bispecific Abs are more effective at killing cancer cells than currently approved antibodies, highlighting the importance of the way C1q binds to cancer targets in activating the complement system.
View Article and Find Full Text PDF

 Patients with systemic lupus erythematosus (SLE) have an increased risk of thrombosis even when they do not have antiphospholipid syndrome (APS). Interactions between complement activation and activated platelets have been suggested in SLE and APS and could play a role in the increased thrombosis risk.  To explore factors potentially related to the prothrombotic pathophysiology in patients with SLE, primary APS, and healthy controls, by investigating lectin pathway proteins (LPPs), complement activation, platelet aggregation, and platelet activation.

View Article and Find Full Text PDF

Background: Patients with hereditary angioedema experience recurrent, sometimes life-threatening, attacks of edema. It is a rare genetic disorder characterized by genetic and clinical heterogenicity. Most cases are caused by genetic variants in the SERPING1 gene leading to plasma deficiency of the encoded protein C1 inhibitor (C1INH).

View Article and Find Full Text PDF

Background: The protease inhibitor inter-α-inhibitor heavy chain H4 (ITIH4) has been described as an acute-phase reactant and could potentially aid in sepsis monitoring and prognostication.

Objectives: To investigate ITIH4 plasma levels in sepsis patients compared with healthy controls and to examine the association between ITIH4 and acute-phase response markers, blood coagulation, and organ dysfunction in sepsis.

Methods: We performed a post hoc study to a prospective cohort study.

View Article and Find Full Text PDF

Antigen binding by B cell receptors (BCR) on cognate B cells elicits a response that eventually leads to production of antibodies. However, it is unclear what the distribution of BCRs is on the naïve B cell and how antigen binding triggers the first step in BCR signaling. Using DNA-PAINT super-resolution microscopy, we find that most BCRs are present as monomers, dimers, or loosely associated clusters on resting B cells, with a nearest-neighbor inter-Fab distance of 20-30 nm.

View Article and Find Full Text PDF

Background And Aims: There is an unmet need for new biomarkers to improve diagnostics and prognostics in primary biliary cholangitis (PBC) and primary sclerosing cholangitis (PSC). Inter-α-inhibitor heavy chain 4 (ITIH4) is an abundant, liver-produced protein, and its synthesis may be altered in liver diseases. We investigated whether ITIH4 plasma concentrations were affected in PBC and PSC patients.

View Article and Find Full Text PDF

Proteolytic activation of the renal epithelial sodium channel (ENaC) is increased by aldosterone. The aldosterone-sensitive protease remains unidentified. In humans, elevated circulating aldosterone is associated with increased urinary extracellular vesicle (uEVs) excretion of mannan-binding lectin associated serine protease-2 (MASP-2).

View Article and Find Full Text PDF
Article Synopsis
  • Atypical hemolytic uremic syndrome (aHUS) is a serious condition that can cause organ failure and is linked to issues with the complement system and the CD46 protein.* -
  • A pediatric patient with aHUS was found to have a new variant in the CD46 gene, which led to reduced surface expression and impaired binding to C3b, a key part of the immune response.* -
  • The study identified that the patient had a higher expression of rare CD46 isoforms, which function less effectively, suggesting multiple mechanisms are involved in the dysfunction of CD46 in aHUS.*
View Article and Find Full Text PDF
Article Synopsis
  • The complement system is vital for the immune response, tagging pathogens and dying cells for removal, but its dysfunction can lead to disease.
  • C3b is a key fragment within this system that enhances activation, making it a desirable target for treatments.
  • Researchers developed a modified nanobody (EWE-hC3Nb1) that specifically binds to C3 degradation products, leading to new fusion proteins (EWEnH and EWEµH) that effectively inhibit C3b activity and show potential for use in rodent models of diseases related to complement dysfunction.
View Article and Find Full Text PDF

Functional antibody deficiency is clinically assessed from antibody responses to vaccination. However, diagnostic vaccination is complex and may fail in practice. We hypothesized that the levels of naturally occurring antibodies against galactose-α-1,3-galactose (αGal) may represent alternative markers of functional antibody capacity.

View Article and Find Full Text PDF